Macrophage phenotype

Macrophage phenotype describes the functional polarization of macrophages into distinct activation states, primarily the M1 (classical) and M2 (alternative) phenotypes, in response to microenvironmental cues (Murray et al., 2014). M1 macrophages are characterized by the production of pro-inflammatory cytokines (e.g., TNF, IL-12) and reactive oxygen species to combat infections and tumors, whereas M2 macrophages produce anti-inflammatory cytokines (e.g., IL-10, TGF-beta) to facilitate tissue repair and remodeling (Yunna et al., 2020). In many cancers, tumor-associated macrophages (TAMs) adopt an M2-like phenotype that suppresses the immune response and promotes angiogenesis, making them a key focus for therapeutic “repolarization” to an M1-like state (Cassetta & Pollard, 2018). Conversely, in chronic inflammatory or autoimmune conditions, therapies may aim to shift macrophages toward an M2 phenotype to resolve inflammation. Because “Macrophage Phenotype” refers to a complex cellular state rather than a single protein, enzyme, or receptor, it is not a discrete molecular target but a therapeutic objective achieved by modulating specific pathways like CSF1R or TLRs (Pathria et al., 2019).

Other names

Macrophage polarizationM1/M2 activationMacrophage activation stateTAM polarization

Modulation of macrophage polarization through the activation or inhibition of specific signaling cascades (e.g., CSF1R, TLR, STAT) to shift the cellular functional state.